AMR interview with Aidian's Medical Science Manager Leena Meriläinen

Antimicrobial resistance (AMR), also known as the Silent Pandemic, is ranked as one of the top three priority health threats by European Commission and the Member States. The World Health Organization (WHO) has also listed AMR as top 10 global health threats facing humanity.

Unnecessary antibiotic use contributes to the development of antibiotic resistance. If antibiotic resistance continues to evolve, it is estimated that by 2050, 10 million people will die each year from AMR-related infections, which will be more than yearly cancer deaths.¹

Respiratory tract infections are the most common reason for antibiotic prescribing in primary care, although the majority of infections have viral cause or are self-limiting. Reducing unnecessary antibiotic use in healthcare is crucial to prevent the development of antibiotic resistance.

Hear from Leena Meriläinen, Medical Science Manager at Aidian, as she discusses the impact of AMR and the role of diagnostic point-of-care testing (POCT) in preventing the development of antibiotic resistance.

Reference

O’Neill J. Review on Antimicrobial Resistance. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations, 2016.